menu toggle
Contact Us
About us
Who we are
Our global reach
Gallery of innovation
Expertise
Why Xcenda?
Areas of expertise
Solutions
Commercialization solutions
Innovative field solutions
Health economics & outcomes research
Reimbursement & policy insights
Real-world evidence
FormularyDecisions
Value and access communications
Global market access consulting
Product launch and commercialization
Market research and advisor networks
Training & learning solutions
Manufacturer solutions from AmerisourceBergen
Our people
Our team
Insights
Insights home
Health Policy Weekly archive
HTA Quarterly archive
Careers
Careers
Life at Xcenda
Student programs
Search for jobs
The AmerisourceBergen network
News and events
Locations
Subscribe to newsletters
Contact us
LinkedIn
X
Instagram
About us
Who we are
Our global reach
Gallery of innovation
Expertise
Why Xcenda?
Areas of expertise
Solutions
Commercialization solutions
Innovative field solutions
Health economics & outcomes research
Reimbursement & policy insights
Real-world evidence
FormularyDecisions
Value and access communications
Global market access consulting
Product launch and commercialization
Market research and advisor networks
Training & learning solutions
Manufacturer solutions from AmerisourceBergen
Our people
Our team
Insights
Insights home
Health Policy Weekly archive
HTA Quarterly archive
Careers
Careers
Life at Xcenda
Student programs
Search for jobs
The AmerisourceBergen network
News and events
Locations
Subscribe to newsletters
Contact us
LinkedIn
X
Instagram
September 3, 2019
A Comprehensive Field Reimbursement Training Program Expands Patient Access
By Xcenda
How Xcenda Designed and Implemented a Best-in-Class Field Reimbursement Training Program
Enter your information to download the case study
Share:
Related Content
Manufacturers
Essential guide to cell and gene therapy (CGT) commercialization
AmerisourceBergen
April 2024
Manufacturers
Pharma in the field: Barrett's story
Xcenda
February 2024
Manufacturers
Podcast: How 2023 will shape the US Biosimilar space for 2024 and beyond
AmerisourceBergen
January 2024
